60 Degrees Pharmaceuticals, INC.
At a glance
Employees1-19
In business since2010
HeadquartersWashington, DC
US patents9
SAM.gov UEIWKN5DNLTVF95
CAGE code71D06
Incorporated inDE
- treatments
- preventive medicines
- vector-borne diseases
- Babesiosis
- clinical pipeline
- therapeutic undertakings
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
9 US patents granted 2017–2025, 6 of them in the five years to SEP 2025.
Pharmaceuticals 9
- Methods for the treatment and prevention of lung infections caused by fungus by administration of tafenoquineUS 12,383,546 · granted AUG 12, 2025
- Regimens of tafenoquine for prevention of malaria in malaria-naïve subjectsUS 11,744,828 · granted SEP 5, 2023
- Methods for the treatment and prevention of lung infections caused by gram-positive bacteria, fungus, or virus by administration of tafenoquineUS 11,633,391 · granted APR 25, 2023
- Dosing regimens of celgosivir for the treatment of dengueUS 11,219,616 · granted JAN 11, 2022
- Dosing regimens of celgosivir for the prevention of dengueUS 11,000,516 · granted MAY 11, 2021
Newest 5 shown · Granted to 60 Degrees Pharmaceuticals LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| 60 Degrees Pharmaceuticals, INC. | Washington | DC | 1–19 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.